Non-Alcoholic Steatohepatitis Pathogenesis: Role of Repair in Regulating the Disease Progression

被引:24
作者
Jung, Youngmi [1 ]
Diehl, Anna Mae [1 ]
机构
[1] Duke Univ, Div Gastroenterol, Durham, NC 27710 USA
关键词
Apoptosis; Liver regeneration; Fibrogenesis; Progenitors; Hedgehog; FATTY LIVER-DISEASE; IKK-BETA; HEDGEHOG; ACTIVATION; APOPTOSIS; VIABILITY; CELLS;
D O I
10.1159/000282092
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Increased hepatocyte apoptosis distinguishes non-alcoholic steatohepatitis (NASH) from non-alcoholic fatty liver disease (NAFLD). Therefore, we postulated that outcomes of NASH depended upon whether or not hepatic regenerative responses could keep pace with the increased rate of hepatocyte death. Methods: To investigate mechanisms that the liver deploys to compensate for increased hepatocyte apoptosis, we studied a transgenic mouse model in which hepatocyte vulnerability to apoptosis was increased due to disruption of NF-kappa B survival signaling. Results: We learned that hepatocyte death is coupled to the expansion of cell types that are involved in liver repair, including progenitors and myofibroblasts, and discovered that the outgrowth of these cell types occurs, at least in part, because dying hepatocytes produce Hedgehog morphogens that enhance the growth of progenitor and myofibroblast populations. The clinical significance of this discovery is supported by evidence that the degree of Hedgehog pathway activation also parallels the severity of liver fibrosis in patients with NASH, a disease in which hepatocyte apoptotic activity has been strongly linked to fibrosis progression. Conclusion: The data generated by studying a mouse model of chronic hepatocyte apoptosis, as well as NASH, a common human liver disease that is characterized by increased rates of hepatocyte apoptosis, are very similar. Both strongly support the concept that repair responses play an important role in controlling the outcomes of NASH. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [21] Role of hepatic iron in non-alcoholic steatohepatitis
    Sumida, Yoshio
    Yoshikawa, Toshikazu
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2009, 39 (03) : 213 - 222
  • [22] Non-alcoholic steatohepatitis
    Romero-Gomez, Manuel
    MEDICINA CLINICA, 2022, 159 (08): : 388 - 395
  • [23] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [24] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [25] Evolving therapies for non-alcoholic steatohepatitis
    Tilg, Herbert
    Moschen, Alexander R.
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (06) : 687 - 696
  • [26] Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis
    Sheng, Wei
    Ji, Guang
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [28] Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
    Yasui, Kohichiroh
    Hashimoto, Etsuko
    Tokushige, Katsutoshi
    Koike, Kazuhiko
    Shima, Toshihide
    Kanbara, Yoshihiro
    Saibara, Toshiji
    Uto, Hirofumi
    Takami, Shiro
    Kawanaka, Miwa
    Komorizono, Yasuji
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2012, 42 (08) : 767 - 773
  • [29] Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
    Waghorn, Philip A.
    Ferreira, Diego S.
    Erstad, Derek J.
    Rotile, Nicholas J.
    Masia, Ricard
    Jones, Chloe M.
    Tu, Chuantao
    Sojoodi, Mozhdeh
    Chen, Yin-ching, I
    Schlerman, Franklin
    Wellen, Jeremy
    Martinez, Robert V. P.
    Tanabe, Kenneth K.
    Fuchs, Bryan C.
    Caravan, Peter
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] In vivo redox metabolic imaging of mitochondria assesses disease progression in non-alcoholic steatohepatitis
    Nakata, Ryosuke
    Hyodo, Fuminori
    Murata, Masaharu
    Eto, Hinako
    Nakaji, Tomoko
    Kawano, Takahito
    Narahara, Sayoko
    Yasukawa, Keiji
    Akahoshi, Tomohiko
    Tomikawa, Morimasa
    Hashizume, Makoto
    SCIENTIFIC REPORTS, 2017, 7